Meg Jardine's Publications

About Meg Jardine's Publications

Honorary Professorial Fellow, The George Institute for Global Health
  • Associate Professor, Faculty of Medicine, UNSW Sydney

  • Chronic kidney disease-mineral and bone disorder: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

    Kidney International Date published:

  • WCN25-1572 DESIGN AND BASELINE CHARACTERISTICS OF THE GLOBAL KIDNEY PATIENT TRIALS NETWORK

    Kidney International Reports Date published:

  • WCN25-1567 Glomerular disease registry and Biobank (GRIT)- design and baseline results

    Kidney International Reports Date published:

  • Canagliflozin reduces oral loop diuretic intensification in patients with type 2 diabetes: A participant-level pooled analysis of the CANVAS and CREDENCE trials

    European Journal of Heart Failure Date published:

  • Cardiovascular, kidney and safety outcomes with canagliflozin in older adults: A combined analysis from the CANVAS Program and CREDENCE trial

    Diabetes, Obesity and Metabolism Date published:

  • Corrigendum to “Study Design and Baseline Characteristics of ALIGN, a Randomized Controlled Study of Atrasentan in Patients With IgA Nephropathy” [Volume 10, Issue 1, January 2025, Pages 217-226]

    Kidney International Reports Date published:

  • Predicting type 2 diabetes and testosterone effects in high-risk Australian men: development and external validation of a 2-year risk model

    European Journal of Endocrinology Date published:

  • The association between sodium-glucose cotransporter 2 inhibitors and contrast-associated acute kidney injury in patients with type 2 diabetes undergoing angiography: a propensity-matched study

    European Journal of Medical Research Date published:

  • Re-thinking kidney function: a new approach to kidney function estimation and the identification of chronic kidney disease

    Medical Journal of Australia Date published:

  • The Global Kidney Patient Trials Network and the CAPTIVATE Platform Clinical Trial Design

    JAMA Network Open Date published:

  • The effects of plasma exchange and glucocorticoids on early kidney function among patients with ANCA-associated vasculitis in the PEXIVAS trial

    Kidney International Date published:

  • Atrasentan in Patients with IgA Nephropathy

    New England Journal of Medicine Date published:

  • Use of SGLT2 Inhibitors and Glucagon-Like Peptide 1 (GLP-1) Receptor Agonists in Australian Primary Care Patients with Type 2 Diabetes Mellitus (T2DM) Stratified by CKD Status

    Journal of the American Society of Nephrology Date published:

  • Risk-Based Implementation of SGLT2 Inhibitors: Insights from the CANVAS Program and CREDENCE Trial

    Journal of the American Society of Nephrology Date published:

  • Cardiovascular, Kidney, and Safety Outcomes with Canagliflozin in Older Adults: A Pooled Secondary Analysis of the CANVAS Program and CREDENCE Trial

    Journal of the American Society of Nephrology Date published:

  • Prognostic Enrichment Using the Klinrisk Model: Insights from Landmark Kidney Disease Clinical Trials

    Journal of the American Society of Nephrology Date published: